Literature DB >> 3818223

Changes of serum lipids and lipoproteins during haemodialysis treatment in dialysed chronic uraemic patients.

A László, M Németh, I Joó, E Kiss, Z Havass, P Szenohradszki.   

Abstract

Changes of serum lipids and lipoproteins were determined quantitatively before and after haemodialysis in chronic uraemic patients. Serum beta-lipoprotein significantly decreased due to haemodialysis, while alpha-lipoprotein and the FFA level significantly increased. Slight correlations were observed between the applied transmembrane pressure and the serum concentration of FFA, HDL-cholesterol or total cholesterol levels. Hyper-beta-lipoproteinemia was found in 70.9 per cent and Frederickson-HLP in 33.3% of the haemodialyzed chronic uraemic patients.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3818223     DOI： 10.1007/bf02084120

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


  12 in total

1.  Uranyl acetate as an excellent fixative for lipoproteins after electrophoresis on agarose gel.

Authors:  A Lózsa
Journal:  Clin Chim Acta       Date:  1974-05-31       Impact factor: 3.786

2.  Postheparin plasma triglyceride lipases in chronic hemodialysis: evidence for a role for hepatic lipase in lipoprotein metabolism.

Authors:  D Applebaum-Bowden; A P Goldberg; W R Hazzard; D J Sherrard; J D Brunzell; J K Huttunen; E A Nikkila; C Ehnholm
Journal:  Metabolism       Date:  1979-09       Impact factor: 8.694

3.  Effects of chronic uremia, hemodialysis, and renal transplantation on plasma lipids and lipoproteins in man.

Authors:  J Bagdade; A Casaretto; J Albers
Journal:  J Lab Clin Med       Date:  1976-01

4.  Observations on lipid metabolism in chronic renal failure, during conservative and haemodialysis therapy.

Authors:  A Noverini; U Zuliani; L Bandini; S Caronna; A Montanari; P Perinotto
Journal:  Eur J Clin Invest       Date:  1976-11-30       Impact factor: 4.686

5.  Hepatic and extrahepatic triglyceride lipase activity in uraemic patients on chronic haemodialysis.

Authors:  K Bolzano; F Krempler; F Sandhofer
Journal:  Eur J Clin Invest       Date:  1978-10       Impact factor: 4.686

6.  Lipid profiles and lipase activities in children and adolescents with chronic renal failure treated conservatively or with hemodialysis or transplantation.

Authors:  K Asayama; H Ito; C Nakahara; A Hasegawa; K Kato
Journal:  Pediatr Res       Date:  1984-08       Impact factor: 3.756

7.  Analysis of cardiovascular risk factors in chronic hemodialysis patients with special attention to the hyperlipoproteinemias.

Authors:  R Hahn; K Oette; H Mondorf; K Finke; H G Sieberth
Journal:  Atherosclerosis       Date:  1983-09       Impact factor: 5.162

8.  Plasma triglyceride secretion and metabolism in chronic renal failure.

Authors:  D G Cramp; T R Tickner; D J Beale; J F Moorhead; M R Wills
Journal:  Clin Chim Acta       Date:  1977-04-15       Impact factor: 3.786

9.  The effect of systemic heparinization on plasma lipoproteins and toxicity in patients on hemodialysis and continuous ambulatory peritoneal dialysis.

Authors:  T Wessel-Aas; J P Blomhoff; T E Widerøe; E Wirum; T Nilsen
Journal:  Acta Med Scand       Date:  1984

10.  A rapid and sensitive fluorometric assay of serum phospholipid.

Authors:  P Jouanel; C Motta; J Delattre; B Dastugue
Journal:  Clin Chim Acta       Date:  1980-08-04       Impact factor: 3.786
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.